Starving Out Malaria Parasites
New class of selective inhibitors paralyze essential plasmodium enzymes
The most dangerous variant of the malaria parasite, Plasmodium falciparum, infects up to 600 million people every year. The search for new effective therapies is thus an urgent area of research. An international team headed by François Diederich has now found a new point of attack: using a novel class of inhibitors, the researchers aim to block certain plasmodium enzymes known as plasmepsins, “starving out” the malaria parasite.
Plasmepsins belong to the family of aspartic protease enzymes. They dismantle human hemoglobin to deliver the amino acids that plasmodia need in order to grow. In developing a new inhibitor, it is important to ensure that it blocks all of the plasmodium plasmepsins while remaining inactive toward human aspartic proteases.
The team of researchers from the Swiss Federal Institute of Technology (ETH) in Zurich, the University of Victoria (Canada), Washington University, St. Louis (USA), and Actelion Pharmaceuticals in Allschwil (Switzerland) started with the previously determined spatial structure of one of the plasmepsins, plasmepsin II. This enzyme has a sort of pocket, formed by the opening of a peptide loop, which seemed to be a suitable point of attack for an inhibitor. On the basis of computer simulations, the researchers successfully developed a family of molecules that fit well into this cavity. The central structural element of these molecules is a bicyclic diamine framework: a six-membered ring of carbon atoms in which two opposite carbon atoms are additionally bridged by the nitrogen of the amino group. A second amino group is bound to a neighboring carbon atom. Like a pincer, the diamine framework clamps onto the catalytic dyad (the two catalytically active aspartate groups) of the plasmepsin. An additional side group fits into a second, adjacent pocket (S1/S3-cavity) of the enzyme.
Enzymatic assays pointed the way to the most effective molecules. It was demonstrated that these did not only block plasmepsin II, for which they were specifically tailored: plasmodium plasmepsins I and IV were both even more strongly inhibited. These enzymes clearly have a very similar structure. In contrast, human aspartyl proteases seem to have a completely different spatial structure because they are not affected at all. In cell cultures of plasmodium-infected red blood cells, the new inhibitors were able to inhibit the growth of the parasites. “We are now trying to further improve the activity of the inhibitors,” says Diederich, “with the goal of developing a new class of antimalaria agents.”
François Diederich | Angewandte Chemie
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...